logo
#

Latest news with #daVinciXiSurgicalSystem

Intuitive Surgical's Da Vinci 5 System Receives CE Mark, Expands Advanced Robotic Surgery Access Across Europe
Intuitive Surgical's Da Vinci 5 System Receives CE Mark, Expands Advanced Robotic Surgery Access Across Europe

Yahoo

time7 days ago

  • Business
  • Yahoo

Intuitive Surgical's Da Vinci 5 System Receives CE Mark, Expands Advanced Robotic Surgery Access Across Europe

Intuitive Surgical Inc. (NASDAQ:ISRG) is one of the best US stocks to buy and hold in 2025. On July 2, Intuitive Surgical announced that its latest da Vinci 5 Surgical System received CE mark approval. This regulatory milestone enables the system's use across adult and pediatric patients in Europe for a spectrum of minimally invasive endoscopic procedures, such as abdominopelvic and thoracoscopic surgeries in urology, gynecology, and general laparoscopy. The da Vinci 5 introduces 50+ enhancements on the foundational da Vinci Xi Surgical System. Key innovations include first-of-its-kind Force Feedback-enabled technology, which allows surgeons to sense pressure and tension during operations. It also features Intuitive's most realistic 3D vision system to date. The system supports 10,000x more computing power than previous models. There's also greater surgeon autonomy through integrated components controlled at the fingertips, a universal user interface for care teams, and dynamic assistance to automate select tasks. A medical team performing minimally invasive surgery with a da Vinci Surgical System. In 2024, the US FDA had already granted 510(k) clearance for the da Vinci 5 Surgical System for use in urology, general, gynecology, and thoracic procedures in adults. In 2024, surgeons performed 410,000+ procedures in Europe using da Vinci systems, contributing to ~17 million procedures performed worldwide to date with Intuitive's technology. Intuitive Surgical Inc. (NASDAQ:ISRG) develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care. While we acknowledge the potential of ISRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.

Intuitive receives CE mark approval for robotic-assisted surgical system
Intuitive receives CE mark approval for robotic-assisted surgical system

Yahoo

time03-07-2025

  • Business
  • Yahoo

Intuitive receives CE mark approval for robotic-assisted surgical system

Intuitive's multi-port robotic-assisted surgical system, da Vinci 5, has secured the CE mark approval for use in both adult and paediatric patients in Europe. This approval allows the system to be utilised for a wide range of minimally invasive endoscopic procedures across abdominopelvic and thoracoscopic procedures, including those in gynaecology, urology, and general laparoscopy. The system builds on the functional design of the da Vinci Xi Surgical System. It features over 150 improvements, contributing to the da Vinci surgical system portfolio that has been leveraged in more than 410,000 procedures in Europe last year. The system delivers improved surgical senses, including Force Feedback-enabled technology and an ergonomic surgeon console for supporting surgeon career longevity. It also streamlines workflow with a universal user interface for care teams and integrates assistance to automate chosen tasks. Additionally, the surgical system delivers actionable insights via an intelligent platform that claims to have 10,000 times more computing power, with new sensors, processors, and software. This provides surgeons with usable data aiding them to quantify, understand, and enhance their surgical performance. Intuitive CEO Dave Rosa said: 'At Intuitive, we're focused on providing healthcare systems across Europe and around the world with thoughtful innovation that solves problems today and into the future. 'After over a decade of careful development, da Vinci 5 is the most advanced and integrated platform we've ever created – designed to enable better outcomes, efficiency, and insights for the future of minimally invasive care.' Last year, da Vinci 5 was cleared by the US Food and Drug Administration for use in various surgical procedures for adults, spanning general, gynaecology, urology, and thoracic. "Intuitive receives CE mark approval for robotic-assisted surgical system" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store